Bisphosphonate therapy in polyostotic fibrous dysplasia.
Kumar
S
S
D000284:Administration, Oral; D019386:Alendronate / Q000008:administration & dosage / Q000627:therapeutic use*; D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D005359:Fibrous Dysplasia, Polyostotic / Q000188:drug therapy*; D006801:Humans
D050071:Bone Density Conservation Agents; D019386:Alendronate